Etanercept treatment of cutaneous granulomas in common variable immunodeficiency

Journal of Allergy and Clinical Immunology

Volumn 117, Issue 4, 2006, Pages 878-882

  Lin, Joann H ^a   Liebhaber, Myron ^b   Roberts, Robert L ^a   Dyer, Zeb ^b   Stiehm, E Richard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Sansurn Santa Barbara Medical Foundation   (United States)

Author keywords

Common variable immunodeficiency; etanercept; granuloma; TNF inhibitors

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; COTRIMOXAZOLE; CYCLOSPORIN; ETANERCEPT; GAMMA INTERFERON; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; MACROLIDE; METHOTREXATE; METRONIDAZOLE; PENICILLIN DERIVATIVE; STEROID; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CELL MEMBRANE; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE DURATION; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL; RECEPTOR BINDING; SKIN GRANULOMA; TREATMENT OUTCOME;

ADOLESCENT; ARM; COMMON VARIABLE IMMUNODEFICIENCY; GRANULOMA; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646020972     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.01.034     Document Type: Article

References (25)

1. Spickett G.P. Current perspectives on common variable immunodeficiency (CVID). Clin Exp Allergy 31 (2001) 536-542
2. Ballow M. Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol 109 (2002) 581-591
3. Cunningham-Rundles C., and Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92 (1999) 34-48
4. Fasano M.B., Sullivan K.E., Sarpong S.B., Wood R.A., Jones S.M., Jones C.J., et al. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 75 (1996) 251-261
5. Aukrust P., Lien E., Kristoffersen A.K., Muller K., Haug C.J., Espevik T., et al. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency-possible immunologic and clinical consequences. Blood 87 (1996) 674-681
6. Smith K.J., and Skelton H. Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-alpha receptor fusion protein. Br J Dermatol 144 (2001) 597-600
7. Siegfried E.C., Prose N.S., Friedman N.J., and Paller A.S. Cutaneous granulomas in children with combined immunodeficiency. J Am Acad Dermatol 25 (1991) 761-766
8. Crystal R.G. Sarcoidosis. In: Isselbacher K.J., Martin J.B., Braunwald E., Fauci A.S., Wilson J.D., and Kasper D.L. (Eds). Harrison's principles of internal medicine (1994), McGraw-Hill, New York 1683-1684
9. Torrelo A., Mediero I.G., and Zambrano A. Caseating cutaneous granulomas in a child with common variable immunodeficiency. Pediatr Dermatol 12 (1995) 170-173
10. Lun K.R., Wood D.J., Juir J.B., and Noakes R. Granulomas in common variable immunodeficiency: a diagnostic dilemma. Australas J Dermatol 45 (2004) 51-54
11. Krupnick A.I., Shim H., Phelps R.G., Cunningham-Rundles C., and Sapadin A.N. Cutaneous granulomatous masquerading as tuberculoid leprosy in a patient with congenital combined immunodeficiency. Mt Sinai J Med 68 (2001) 326-330
12. Mrusek S., Marx A., Kummerle-Deschner J., Tzaribachev N., Enders A., Riede U.N., et al. Development of granulomatous common variable immunodeficiency subsequent to infection with Toxoplasma gondii. Clin Exp Immunol 137 (2004) 578-583
13. O'Conner C.M., and Fitzgerald M.X. Speculations on sarcoidosis. Respir Med 86 (1992) 277-282
14. Mechanic L.J., Dikman S., and Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann Intern Med 127 (1997) 613-617
15. Wright J.J., Wagner D.K., Blaese R.M., Hagengruber C., Waldmann T.A., and Fleisher T.A. Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features. Blood 76 (1990) 2046-2051
16. Mullighan C.G., Fanning G.C., Chapel H.M., and Welsh K.I. TNF and Lymphotoxin alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 159 (1997) 6236-6241
17. Braun J., Baraliakos X., Lising J., and Sieer J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52 (2005) 2447-2451
18. Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., et al. Short term trial of etanercept in Behcet's disease: a double blind, placebo controlled study. J Rheumatol 32 (2005) 98-105
19. Lin M.H., Hsu C.K., and Lee J.Y. Successful treatment of recalcitrant pemphigus vulgaris and pemphigus vegetans with etanercept and carbon dioxide laser. Arch Dermatol 141 (2005) 680-682
20. Pasternack F.R., Fox L.P., and Engler D.E. Silicone granulomas treated with etanercept. Arch Dermatol 141 (2005) 13-15
21. Etanercept: drug Information. UpToDate. Available at: www.uptodate.com. Accessed 2005.
22. Mohan V.P., Scanga C.A., Yu K., Scott H.M., Tanaka K.E., Tsang E., et al. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69 (2001) 1847-1855
23. Mohan A.K., Cote T.R., Block J.A., Manadan A.M., Siegel J.N., and Raun M.M. Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis 39 (2004) 295-299
24. Hatab A.Z., and Ballas Z. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J Allergy Clin Immunol 116 (2005) 1161-1162
25. Thatayatikom A., Thatayitom S., and White A.J. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann Allergy Asthma Immunol 95 (2005) 293-300